INS and metabolic syndrome: Present population epidemiological and animal studies suggest that CGA, which in vivo can regulate glucose and lipid metabolism and improves insulin sensitivity, may be capable of preventing and treating obesity, diabetes mellitus, and metabolic syndrome.